DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Polycystic ovary syndrome

Essential points for quick revision.

!
Escalate

Rapid virilisation, a markedly abnormal androgen result, postmenopausal onset, severe abnormal bleeding with haemodynamic compromise, or acute pelvic pain with pregnancy possibility requires urgent assessment for an androgen-secreting tumour, haemorrhage, ectopic pregnancy or torsion. Do not route these presentations through routine PCOS review.

Synopsis

Diagnose polycystic ovary syndrome only after excluding important mimics, then protect endometrial, metabolic, reproductive and psychological health through goals chosen with the individual.

  • PCOS is a heterogeneous endocrine-metabolic syndrome, not an ultrasound description; polycystic ovarian morphology alone does not establish the diagnosis.
  • In adults, diagnose after excluding mimics when two of ovulatory dysfunction, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology are present under the current guideline framework.
  • In adolescents, normal pubertal irregularity and multifollicular ovaries create overdiagnosis; require persistent cycle disturbance plus hyperandrogenism and use specialist age-from-menarche criteria rather than adult shortcuts.

Key red flags

Endometrial risk

Very infrequent bleeding, prolonged amenorrhoea, persistent abnormal bleeding or a thickened endometrium increases concern for hyperplasia and requires a protection and investigation plan.

Investigation priorities

01
Pregnancy testFirst step

Exclude the commonest physiological cause of absent or irregular bleeding before endocrine interpretation.

Management branches

DiagnoseAdult PCOS assessment

Persistent irregular cycles, hirsutism, acne or biochemical androgen excess in an adult.

  1. Clarify cycle pattern, pregnancy possibility, medications, hair progression, weight trajectory, sleep, mood, eating, fertility goals and red-flag virilisation; examine blood pressure, androgen signs and thyroid or Cushing features.
  2. Exclude pregnancy and common mimics with testosterone and SHBG, thyroid testing, prolactin and early-morning 17-hydroxyprogesterone, adding specialist tests only when indicated.

Key medicines

Combined hormonal contraceptionUse a licensed low-risk preparation and schedule selected through the current UK contraceptive eligibility framework.
Intermittent oral progestogenGive the locally recommended course often enough to provide endometrial protection when spontaneous bleeding is infrequent.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom